Journal
SCIENCE
Volume 294, Issue 5540, Pages 169-173Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1064852
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL-53917, HL-18574, HL66681] Funding Source: Medline
Ask authors/readers for more resources
Comparison of genomic DNA sequences from human and mouse revealed a new apolipoprotein (APO) gene (APOAV) located proximal to the well-characterized APOAI/CIII/AIV gene cluster on human 11q23. Mice expressing a human APOAV transgene showed a decrease in plasma triglyceride concentrations to one-third of those in control mice; conversely, knockout mice lacking Apoav had four times as much plasma triglycerides as controls. In humans, single nucleotide polymorphisms (SNPs) across the APOAV locus were found to be significantly associated with plasma triglyceride levels in two independent studies. These findings indicate that APOAV is an important determinant of plasma triglyceride levels, a major risk factor for coronary artery disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available